Glaxo
GlaxoSmithKline
Garnier
aims
after
afternoon
anti-depressants
and
at
absorbed
also
allergies
as
high
hit
had
he
profit
profits
profits,
products
progress."
price
particularly
pace
pipeline
pence.
performance
fall
failure
firm
for
forward
saw
says
sales
said
said.
share
still
success
such
several
it
its
is
in
important
9%
last
lost
look
lift
year
year".
years.
to
the
trade
treatment
treatments
trial
terms
£6.2bn
£1.5bn
($11.5bn),
but
business.
biggest
be
been
Europe's
drugmaker
drugs,
drug.
during
dollar
down
deliver
despite
development
depression,
discontinued
disappointing
diabetes,
recovery
research
results.
relying
2005
2005,"
2004.
on
of
obesity
obesity,
over
our
way.
was
weak
were
will
Cheap
Chief
copies
confident
continuing
conditions
company
can
cancer,
clinical
Paxil
Wellbutrin,
global
generics
grow
growth
good
up
1%
1218
The
new
now
executive
experimental
early
Jean-Pierre
"difficult
"The
"2005
In
London
Mr
managing
means
key
known
However,
HIV/AIDS
'771,